JPM Research Update — August 28, 2026
Updated Thesis
JPMorgan Chase & Co. is a diversified financial services giant operating through Consumer & Community Banking, Commercial & Investment Bank, and Asset & Wealth Management segments. The company benefits from a strong brand, extensive scale, and a leading position in investment banking and payments, underpinned by CEO Jamie Dimon's long-tenured leadership.
The investment grade as of this refresh is B — solid business quality. B-tier business, fair valuation with 20% upside to fair value.
Key Metrics at a Glance
- Revenue growth: +17.9% year over year
- Net margin: 21.9%
- Fair value upside: +20.0% to our estimate of $425
Current price: $354.22
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. JPMorgan Chase & Co. remains in our covered universe with a solid-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full JPM research →](/stocks/JPM)